The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study

The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study

Abstract Background The combination of targeted therapy and immunotherapy has improved the clinical outcomes of unresectable hepatocellular Carcinoma (HCC). However, the overall prognosis remains suboptimal. This study aims to evaluate the efficacy and safety of a novel combination of radiofrequency...

Full description

Bibliographic Details
Main Authors: Xishu Wang, Ximin Sun, Yongrong Lei, Lingyan Fang, Yuedi Wang, Kai Feng, Feng Xia
Format: Article
Language:English
Published: BMC 2024-08-01
Series:BMC Cancer
Subjects:
Unresectable hepatocellular carcinoma
Radiofrequency ablation
Lenvatinib
Sintilimab
Locoregional therapy
Online Access:https://doi.org/10.1186/s12885-024-12779-5

Internet

https://doi.org/10.1186/s12885-024-12779-5

Similar Items